Overcoming the Development and Manufacturing Challenges Associated with Nucleic Acid Therapeutics

Life Sciences, Pharma Manufacturing & Supply Chain, Drug Discovery & Development, Biosimilars,
  • Monday, December 13, 2021 | 2pm EST (11am PST)
  • 60 min

Nucleic acid therapeutics include mRNA and non-viral DNA in various forms. They can be used as vaccines or medicines and are usually delivered as lipid nanoparticles. While nucleic acid therapeutics have substantial advantages over traditional biologics, their development and manufacturing processes can be complex and require diverse capabilities and expertise.

In this presentation, our featured speaker will discuss those challenges and how Curia meets them using combined biology and chemistry expertise.

Register for this webinar to learn about:

  • An overview of nucleic acid therapeutics development and challenging areas
  • Nucleic acid therapeutics drug substance manufacturing
  • Lipid nanoparticle formulation and testing
  • Key materials and supply

Speaker

http://Hua%20Tu,%20Curia

Hua Tu, Chief Technology Officer, Curia

Hua Tu joined Curia via the LakePharma acquisition in September 2021. As Chief Technology Officer, he is responsible for technology and innovation at Curia.

Hua brings more than 20 years of experience in the biotech industry to Curia. He founded LakePharma, the biologics company, in 2009 and built the business into one of the premium US-based biologics service providers. Before founding LakePharma, he spent 11 years at Amgen working on various drug development programs.

Hua earned a Bachelor of Science in biochemistry and a PhD in molecular cell biology from SUNY Stony Brook. He has authored more than 30 peer-reviewed publications.

Message Presenter

Who Should Attend?

  • Drug discovery scientists
  • Drug development and manufacturing professionals

What You Will Learn

Join this webinar to learn about:

  • An overview of nucleic acid therapeutics development and challenging areas
  • Nucleic acid therapeutics drug substance manufacturing
  • Lipid nanoparticle formulation and testing
  • Key materials and supply

Xtalks Partner

Curia

Curia, formerly AMRI, is a leading contract research, development and manufacturing organization providing products and services from R&D through commercial manufacturing of large and small molecules to pharmaceutical and biopharmaceutical customers. Curia’s more than 3,700 employees at 30 locations across the U.S., Europe and Asia help its customers advance from curiosity to cure. Learn more at CuriaGlobal.com.

Media Partner

The original site for employees in the pharma, medical, diagnostic and related industries. Our hand-curated daily news feed and active message forums will keep you informed.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account